Results for tag: "Glaucoma Surgical Devices"

The Glaucoma Surgical Devices market is a specialized sector within the broader optical industry, focusing on medical devices designed to treat glaucoma. Glaucoma is a group of eye conditions that can lead to vision loss by damaging the optic nerve, often related to increased intraocular pressure (IOP). Surgical treatment for glaucoma is considered when pharmacological and laser therapies are inadequate to control IOP. The devices used in these procedures aim to either reduce the production of aqueous humor (fluid in the eye) or improve its outflow, hence lowering IOP and preventing further optic nerve damage. The technology spectrum of glaucoma surgical devices includes various implants and stents, lasers, and microsurgical instruments. Innovations in this market are geared towards minimally invasive glaucoma surgeries (MIGS) to reduce complications and enhance recovery. Surgeons perform these procedures in hospital outpatient departments, ambulatory surgical centers, and ophthalmology clinics. Prominent companies operating in the glaucoma surgical devices market include Alcon (a division of Novartis), Allergan (now part of AbbVie), Glaukos Corporation, New World Medical, and Santen Pharmaceutical. These companies are engaged in research and development, manufacturing, and distribution of various surgical products to address the diversified needs of patients suffering from glaucoma. Show Less Read more